0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
424.83%
10Y revenue/share CAGR above 1.5x XRF.AX's 151.40%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-91.33%
Negative 5Y CAGR while XRF.AX stands at 74.52%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-48.01%
Negative 3Y CAGR while XRF.AX stands at 49.22%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
93.13%
10Y OCF/share CAGR at 50-75% of XRF.AX's 132.15%. Martin Whitman might fear a structural deficiency in operational efficiency.
-121.25%
Negative 5Y OCF/share CAGR while XRF.AX is at 1139.05%. Joel Greenblatt would question the firm’s operational model or cost structure.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-111.18%
Negative 3Y CAGR while XRF.AX is 72.97%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.